Shopping Cart
Remove All
Your shopping cart is currently empty
SQ-31765 is a blocker of benzazepine calcium channel.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,670 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $2,180 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $2,800 | 6-8 weeks | 6-8 weeks |
| Description | SQ-31765 is a blocker of benzazepine calcium channel. |
| In vivo | SQ-31765 (SQ 31,765) effectively mitigates ischemia severity independent of myocardial blood flow or hemodynamic changes. In a study, anesthetized dogs were administered saline (n=6), SQ-31765 (n=6; 0.2 mg/kg), or SQ 32,189 (n=6; 0.2 mg/kg) intravenously 10 minutes before inducing ischemia. The study examined the compound's impact on pacing-induced ST-segment elevation and myocardial blood flow during left anterior descending coronary artery stenosis. SQ-31765 significantly reduced ST-segment elevation (P<0.05) at 10, 40, and 70 minutes post-infusion, showing a notable reduction (5.9±1.4 mV at 70 minutes) compared to the saline group (12.0±1.4 mV at 70 minutes). All test groups exhibited decreased subendocardial flow due to left anterior descending coronary artery stenosis during atrial pacing before drug administration, highlighting SQ-31765's protective effects against pacing-induced myocardial injury. |
| Molecular Weight | 464.48 |
| Formula | C24H27F3N2O4 |
| Cas No. | 138383-07-0 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.